cGxP.wire https://validator.w3.org/feed/docs/rss2.html SpinaFX Earns CE Mark for Triojection Spine System Zentalis to Present Azenosertib Data at ESMO 2026 Veradermics Presents VDPHL01 Data at AAD 2026 Aptar Pharma Launches Injectable Drug Development Framework Amneal Wins FDA Approval for Expanded Iohexol Portfolio Evaxion Highlights Phase 2 EVX-01 Melanoma Results SS Innovations Highlights Surgical Robotics at SRS 2026 Galmed Accelerates Heart Failure Innovation with Aramchol GRAIL Teams with Priority Health to Expand Galleri Vanda Gains EMA Orphan Status for Imsidolimab in GPP Boehringer Ingelheim Wins EU Approval for JASCAYD Merck Wins FDA Approval for Oral PCSK9 Drug LIPFENDRA Clearmind Reports Positive Intranasal MEAI Results Lilly Acquires AtaiBeckley to Advance Depression Therapies Eurofins Viracor Expands Cytokine Testing Portfolio Mission Sells MTX652 to Dimerix in $292M Deal GSK Completes Nuvalent Acquisition to Expand Lung Cancer Moderna Doses First Patient in mRNA-4200 Cancer Trial Takeda Reports Strong Phase 3 Zasocitinib Results InnoCare Reports Positive Phase II Soficitinib Results DarioHealth Wins Fifth Fortune 50 Employer Contract Saluda Medical Receives FDA Approval for CAP24 Surgical Paddle Lead Inspirata AI Strengthens Cancer Registry Platform with AI FDA Accepts Shionogi’s sNDA for Fetroja in Pediatric Gram-Negative Infections Novartis Fabhalta Wins Full FDA Approval for IgAN Insmed Reports Positive 12-Month TPIP PAH Study Data Regentis Wins European Approval for New GelrinC Process Diagonal Therapeutics Doses First DIAG723 HHT Patient Intensity Therapeutics Restarts Phase 2 TNBC Trial Vector Expands Patent Portfolio for Precision Drug Delivery Kairos Announces Positive Interim Phase 1 ENV-105 Data Cumulus Unveils AI Tool for Alzheimer’s Trial Screening Kaneka Advances Ubiquinol Quality with New Testing Phase Orasis Files Australia NDA for BESKA Eye Drops Anova and Nouveau Team Up on Kromastat Development Zepto Life Launches FungiFlex Tests for Rapid Fungal Diagnosis Grifols Doses First Patients in Two Phase 3 Trials Plus Therapeutics Partners with GTC to Expand CNSide Platform Persephoni Backs SelSym to Advance Trauma Bleeding Care Medicus Pharma Advances Optimized Phase 2 Teverelix Study Genentech Wins FDA Priority Review for Gazyva in pMN Angelini Pharma Completes $4.1 Billion Acquisition of Catalyst Pharmaceuticals Novo Nordisk Secures EU Approval for Oral Wegovy Merck’s KEYTRUDA Tops Chemo in dMMR Endometrial Cancer Kelun-Biotech Advances SKB575 with China IND Approval UroGen Secures U.S. Patent Protection for ZUSDURI Through 2044 Tonix Publishes Mpox Study Supporting TNX-801 Vaccine MAXONA Wins FDA IND Clearance for MAX-001 Phase 2 Trial Lakewood-Amedex Advances Nu-3 Gel Toward Phase 2a Trial Sinopia Reports Positive Preclinical Parkinson’s Findings